rs558457816
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000482565.1(HBA2):n.141C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0047 ( 0 hom., cov: 4)
Exomes 𝑓: 0.0081 ( 64 hom. )
Failed GnomAD Quality Control
Consequence
HBA2
ENST00000482565.1 non_coding_transcript_exon
ENST00000482565.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.782
Publications
0 publications found
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
HBA2 Gene-Disease associations (from GenCC):
- alpha thalassemia spectrumInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- erythrocytosis, familial, 7Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- hemoglobin M diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Hb Bart's hydrops fetalisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hemoglobin H diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Heinz body anemiaInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- methemoglobinemia, alpha typeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-173034-C-T is Benign according to our data. Variant chr16-173034-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 439773.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.00812 (3751/461772) while in subpopulation NFE AF = 0.0105 (2867/273496). AF 95% confidence interval is 0.0102. There are 64 homozygotes in GnomAdExome4. There are 1857 alleles in the male GnomAdExome4 subpopulation. Median coverage is 2. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 64 AD,AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00474 AC: 86AN: 18128Hom.: 0 Cov.: 4 show subpopulations
GnomAD3 genomes
AF:
AC:
86
AN:
18128
Hom.:
Cov.:
4
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00696 AC: 427AN: 61338 AF XY: 0.00673 show subpopulations
GnomAD2 exomes
AF:
AC:
427
AN:
61338
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00812 AC: 3751AN: 461772Hom.: 64 Cov.: 2 AF XY: 0.00761 AC XY: 1857AN XY: 243904 show subpopulations
GnomAD4 exome
AF:
AC:
3751
AN:
461772
Hom.:
Cov.:
2
AF XY:
AC XY:
1857
AN XY:
243904
show subpopulations
African (AFR)
AF:
AC:
27
AN:
11878
American (AMR)
AF:
AC:
168
AN:
24782
Ashkenazi Jewish (ASJ)
AF:
AC:
125
AN:
14790
East Asian (EAS)
AF:
AC:
0
AN:
30956
South Asian (SAS)
AF:
AC:
100
AN:
48322
European-Finnish (FIN)
AF:
AC:
192
AN:
29438
Middle Eastern (MID)
AF:
AC:
7
AN:
1960
European-Non Finnish (NFE)
AF:
AC:
2867
AN:
273496
Other (OTH)
AF:
AC:
265
AN:
26150
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
218
436
655
873
1091
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00470 AC: 85AN: 18098Hom.: 0 Cov.: 4 AF XY: 0.00535 AC XY: 43AN XY: 8040 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
85
AN:
18098
Hom.:
Cov.:
4
AF XY:
AC XY:
43
AN XY:
8040
show subpopulations
African (AFR)
AF:
AC:
3
AN:
2616
American (AMR)
AF:
AC:
12
AN:
2298
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
502
East Asian (EAS)
AF:
AC:
0
AN:
1324
South Asian (SAS)
AF:
AC:
2
AN:
926
European-Finnish (FIN)
AF:
AC:
2
AN:
1000
Middle Eastern (MID)
AF:
AC:
0
AN:
124
European-Non Finnish (NFE)
AF:
AC:
62
AN:
8922
Other (OTH)
AF:
AC:
1
AN:
314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 31, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Apr 21, 2022
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.